PGM
OPRX icon

Parian Global Management’s OptimizeRx OPRX Stock Holding History

Parian Global Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$104K Buy
+7,000
New +$138K 0.34% 30
2021
Q3 		– Sell
-50,774
Closed -$3.14M – 43
2021
Q2 		$3.14M Buy
+50,774
New +$2.58M 1.35% 22

Other funds holding OPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Parian Global Management's OPRX Position: Q3 2022 in Review

Parian Global Management opened a new position in OptimizeRx (OPRX) in Q3 2022: 7,000 shares worth $104K. The stake represents 0.34% of the portfolio and ranks #30 among its holdings. This is a return to the name: Parian Global Management previously reported a position in OPRX as recently as Q2 2021.

Parian Global Management first reported a position in OPRX in Q2 2021 and has held it in 2 quarters since. The position peaked at $3.14M in Q2 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q3 2022.

  • Parian Global Management held 7,000 shares of OptimizeRx worth $104K as of Q3 2022.
  • OptimizeRx was a new Parian Global Management position in Q3 2022.
  • OptimizeRx made up 0.34% of Parian Global Management's portfolio in Q3 2022, its #30 holding.
  • Parian Global Management first reported a position in OptimizeRx in Q2 2021 and has held it in 2 quarters since.
  • Parian Global Management's OptimizeRx position peaked at $3.14M in Q2 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2022.

Based on Parian Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.